knowledge -WSS

knowledge

author：knowledge 2025-10-01 15:29:19 - browse：828

Pascal Soriot - Senate Finance Committee — AstraZeneca CEO Pascal Soriot Jacquelyn Martin/AP

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals. On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.

“We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

WSS

Bernie Sanders bashes nonprofit hospitals over their tax breaks

How doctors and nurses shape Google's AI

HHS's proposed rule does nothing to address the climate crisis

Black vets could get higher VA benefits if race not used in lung test

Primary care doctor shortage won't be solved by free med school tuition

Can gargling with Listerine treat gonorrhea of the mouth?

Wikipedia

knowledge

explore

Hepatitis C has a cure — but many Americans still lack access to it

Akero's treatment for NASH falls short in cirrhosis study

Medicare proposal to cover medical devices draws a mixed reaction

Novel spinal cord stimulator treats paralysis without surgery

After affirmative action ruling, medical educators look to 'holistic review'

A revolution in caring for preterm infants

In Memoriam: Notable people who died in 2023

Class action alleges UnitedHealth concealed DOJ probe

Jerome Adams on the need for new antivirals for Covid

AI for drug discovery: Experts on separating hype from reality

hotspot

Nick Jonas talks about managing diabetes along with his career

Sepsis can kill a child within hours. Here's how hospitals are fighting back

As billionaires fund anti

Humana CEO Bruce Broussard to step down in 2024

How doctors and nurses shape Google's AI

Peter Marks talks Operation Warp Speed for Rare Diseases

Wikipedia

Wikipedia

hotspot

focus